An Act amending the act of April 17, 2016 (P.L.84, No.16), known as the Medical Marijuana Act, in preliminary provisions, further providing for definitions.
Summary
HB533 amends Pennsylvania’s Medical Marijuana Act by revising the statutory definition of “serious medical condition” in the act’s preliminary provisions. The bill keeps the existing list of qualifying conditions—such as cancer, HIV/AIDS, ALS, Parkinson’s disease, multiple sclerosis, epilepsy, inflammatory bowel disease, Crohn’s disease, PTSD, glaucoma, sickle cell anemia, autism, and severe chronic pain—but makes one targeted change to the catch-all language.
Specifically, the bill adds a new category for “a condition deemed a serious medical condition by a practitioner,” which would allow a treating practitioner to identify additional qualifying conditions on a case-by-case basis. The bill also retains the existing provision allowing other conditions recommended by the advisory board and approved by the secretary to qualify. If enacted, the amendment would take effect 60 days after passage.
Impact
HB533 would broaden access to Pennsylvania’s medical marijuana program by expanding who may qualify as a patient under the definition of “serious medical condition.” The change would affect patient certification decisions made by practitioners and could increase the number of conditions eligible for medical marijuana treatment without requiring a separate advisory board recommendation or secretary approval in every instance. The bill amends the Medical Marijuana Act’s definitions section and would directly affect patients, certifying practitioners, and the Department of Health’s administration of the program.
Sentiment
No committee transcript or vote record was provided, so there is no documented floor or committee sentiment to assess. Based on the bill text and sponsorship, the measure appears to be a patient-access expansion within the medical marijuana framework, which typically draws support from advocates for broader treatment options and may prompt caution from those concerned about loosening eligibility standards. The available record does not show recorded opposition or support.
Contention
The main point of contention is likely the new practitioner-based authority to deem a condition a serious medical condition. Supporters would view this as a flexible, patient-centered way to adapt to individual medical needs, while critics may argue it reduces uniformity and could expand eligibility beyond the intent of the original statute. A secondary issue is whether the existing advisory board and secretary approval process should remain the primary gatekeeper for new qualifying conditions, rather than allowing individual practitioners to make that determination.
In preliminary provisions, further providing for definitions; in practitioners, further providing for pr actitioner registration; in medical marijuana controls, further providing for electronic tracking and for laboratory; and, in Medical Marijuana Advisory Board, further providing for advisory board.